Patent intelligence · US
US 7722902
Solid dosage form for providing a dietary supplement
Solid dosage form for providing a dietary supplement
Patent details — US 7722902
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 25, 2010
- Expiration
- May 20, 2030
- Applicant
- Sakura Properties, LLC
- Claims
- 1
- CPC classes
- A61K, A61K8/29, A61K8/9711, A61K8/9717
Quick answer
US 7722902 (Solid dosage form for providing a dietary supplement) is held by Sakura Properties, LLC. Status: granted. Granted May 25, 2010. Expires May 20, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Sakura Properties, LLC
- Grant date
- Expiration
- Claims
- 1
- CPC classes
- A61K, A61K8/29, A61K8/9711, A61K8/9717, A61K8/9789, A61P
More from Sakura Properties, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12377026
Dental adhesive material kit
granted -
US 12358210
Resin composition for stereolithography
granted -
US 12344691
Resin composition for stereolithography
granted -
US 12214061
Adhesive composition for dental use
granted -
US 12208148
Dental restorative curable composition
granted -
US 12145888
Zirconia molded body and pre-sintered body capable of being sintered in short time
granted -
US 12138325
Dental composition
granted
Frequently asked questions
What is US patent 7722902?
US 7722902 (Solid dosage form for providing a dietary supplement) is held by Sakura Properties, LLC. Status: granted. Granted May 25, 2010. Expires May 20, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7722902?
Sakura Properties, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 132 pharmaceutical patents for this assignee.
When does US 7722902 expire?
Our index shows an expiration date of May 20, 2030 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.